Pharmacokinetics, pharmacodynamics, and tolerability of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0, and 1.5 milligrams) in healthy male volunteers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples